Skip to main content
Premium Trial:

Request an Annual Quote

The Downside of Sleeping Pills


A study published in the journal BMJ Open shows that Americans who take sleeping pills are more likely to develop cancer and die prematurely than people who don't take the pills, reports Melissa Healy in the Los Angeles Times' Booster Shots blog. The study also revealed that even small amounts of sleeping pills like Ambien or Lunesta can raise a person's risk of cancer, Healy says. The heaviest users of these drugs were 35 percent more likely to be diagnosed with cancer than those who did not take them, the study found.

However, Healy adds, "Studies such as this one do not establish whether sleep drugs are a cause of the increased cancers and deaths or whether, perhaps, those who are at greater risk of dying or developing cancer are simply more likely to seek a prescription for sleep problems."

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.